ReVaPreF2: Respiratory Variations For Predicting Fluid Responsiveness 2

Sponsor
University Hospital, Lille (Other)
Overall Status
Completed
CT.gov ID
NCT03066375
Collaborator
(none)
55
1
1
37
1.5

Study Details

Study Description

Brief Summary

Objectives: To investigate whether respiratory variations of inferior vena cava diameters (cIVC) predict fluid responsiveness in spontaneously breathing patients with septic acute circulatory failure and irregular heartbeats.

Design: Prospective, bicentric study, intensive care units.

Patients and measures: Spontaneously breathing patients with sepsis and clinical signs of acute circulatory failure are included. A positive response to fluid loading (FL) is defined as an increase of the stroke volume (SV) >10%. The investigators measured the minimum inspiratory and maximum expiratory diameters of the IVC (idIVC and edIVC) during standardized (st) and unstandardized (ns) breathing. The investigators calculated cIVCst and cIVCns before a 500ml-colloid FL.

Condition or Disease Intervention/Treatment Phase
  • Device: Echocardiography-Doppler
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
55 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Diagnostic Accuracy of the Inferior Vena Cava Collapsibility to Predict Fluid Responsiveness in Spontaneously Breathing Patients With Sepsis, Acute Circulatory Failure, and Irregular Cardiac Rhythm
Study Start Date :
May 1, 2012
Actual Primary Completion Date :
May 1, 2015
Actual Study Completion Date :
Jun 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Echocardiography-Doppler

Ultrasonographic recordings, systemic arterial pressure, heart rate, and respiratory rate are recorded immediately before and after volume expansion (VE), performed as a 30-minute infusion of 500 mL of 4% gelatin. Inferior Vena Cava diameters are measured during spontaneous and standardized respiratory cycles. Stroke volume is measured during spontaneous respiratory cycles.

Device: Echocardiography-Doppler
Ultrasonographic recordings are recorded immediately before and after volume expansion (VE), performed as a 30-minute infusion of 500 mL of 4% gelatin. Inferior Vena Cava diameters are measured during spontaneous and standardized respiratory cycles. Stroke volume is measured during spontaneous respiratory cycles.

Outcome Measures

Primary Outcome Measures

  1. respiratory variations in inferior vena cava diameters with respect to the response to fluid resuscitation, assessed by the area under the ROC curve [during 30 minutes of the volume expansion]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients of the intensive care units of the Lille university-hospital and of the Valencienne general hospital.

  • Age greater than or equal to 18.

  • Patient insured

  • Spontaneous breathing without ventilatory support or intubation or tracheotomy.

  • Irregular cardiac rhythm

  • Prescription by the physician in charge of the patients of a 500 mL volume expansion in less than 30 minutes.

  • Patients with sepsis with at least one sign of acute circulatory failure:

  • Tachycardia with heart rate> 100/min

  • systolic blood pressure <90mmHg or a decrease >40mmHg in previously hypertense patient

  • Oliguria <0.5ml/kg/hour for at least one hour

  • skin mottling

Exclusion Criteria:
  • high-grade aortic insufficiency

  • transthoracic echogenicity unsuitable for measuring the stroke volume or inferior vena cava diameters

  • clinical signs of active exhalation

  • clinical or ultrasonographic evidence of pulmonary edema due to heart failure

  • pregnancy

  • abdominal compartment syndrome

  • regular cardiac rhythm

Contacts and Locations

Locations

Site City State Country Postal Code
1 Intensive Care Department, Salengro Hospital,CHRU Lille France

Sponsors and Collaborators

  • University Hospital, Lille

Investigators

  • Principal Investigator: Sebastien Preau, MD, PhD, University Hospital, Lille

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Lille
ClinicalTrials.gov Identifier:
NCT03066375
Other Study ID Numbers:
  • 2011_46
  • 2011-A01598-33
First Posted:
Feb 28, 2017
Last Update Posted:
Feb 28, 2017
Last Verified:
Feb 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Lille
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 28, 2017